ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceuticals

NYC Drug Discovery Institute Launches

by Lisa M. Jarvis
October 14, 2013 | APPEARED IN VOLUME 91, ISSUE 41

The Tri-Institutional Therapeutics Discovery Institute, a collaboration among three New York City-based academic centers, has launched with $20 million in philanthropic funding. The partnership among Memorial Sloan-Kettering Cancer Center, Rockefeller University, and Weill Cornell Medical College brings together experts in medicinal chemistry, compound screening, and drug development. Medicinal chemistry will take place at labs that are set to open in January at Weill Cornell. The nonprofit institute has partnered with Takeda Pharmaceutical to develop small-molecule drugs.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment